GHK Base
Typical Dosage
Topical 0.05-1% concentration
Injection: 1-5 mg
Administration
Topical • Injection
Half-Life
Short peptide; exact human half-life not well characterized
Mechanism of Action
Skin repair and remodeling|Collagen synthesis research|Wound healing|Hair follicle biology
Research Protocol Summary
Evidence Level
Human Clinical / Marketed
Species Studied
Human • Mouse
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…